牵正散加减联合甲钴胺对周围性面神经麻痹患者面神经功能的影响  

Effect of Qianzheng Powder Combined with Mecobalamin on Facial Nerve Function in Patients with Peripheral Facial Paralysis

作　　者：肖俊俊 XIAO Junjun(Ji'an County People's Hospital,Ji'an 343100,Jiangxi,China)

机构地区：[1]吉安县人民医院,江西吉安343100

出　　处：《医学信息》2024年第23期135-138,共4页Journal of Medical Information

摘　　要：目的观察牵正散加减联合甲钴胺对周围性面神经麻痹患者面神经功能的影响。方法选取2020年3月-2022年12月在我院诊治的60例周围性面神经麻痹患者为研究对象,采用随机数字表法分为对照组(n=30)和观察组(n=30),对照组采用甲钴胺治疗,观察组在对照组基础上联合采用牵正散加减治疗。比较两组治疗效果、面神经麻痹症状评分、面神经功能(Portmann)评分、面部残疾指数(FDI)及复发率。结果观察组总有效率(96.67%)高于对照组(83.33%)(P<0.05);两组治疗后面神经麻痹症状评分均较治疗前升高,且与对照组比较,观察组更高(P<0.05);两组治疗后Portmann评分均较治疗前升高,且与对照组比较,观察组更高(P<0.05);两组治疗后FDIS、FDIP评分均较治疗前升高,且与对照组比较,观察组更高(P<0.05);随访7个月,观察组复发率为3.33%,低于对照组的16.67%(P<0.05)。结论牵正散加减联合甲钴胺治疗周围性面神经麻痹具有良好的效果,可减轻患者面神经麻痹症状,促进面神经功能恢复,改善面部残疾指数和复发率,值得临床加以应用。Objective To observe the effect of Qianzheng powder combined with mecobalamin on facial nerve function in patients with peripheral facial paralysis.Methods A total of 60 patients with peripheral facial paralysis diagnosed and treated in our hospital from March 2020 to December 2022 were selected as the research objects.They were divided into control group(n=30)and observation group(n=30)by random number table method.The control group was treated with mecobalamin,and the observation group was treated with Qianzheng powder on the basis of the control group.The treatment effect,facial paralysis symptom score,facial nerve function(Portmann)score,facial disability index(FDI)and recurrence rate were compared between the two groups.Results The total effective rate of the observation group(96.67%)was higher than that of the control group(83.33%)(P<0.05).After treatment,the scores of facial nerve paralysis symptoms in the two groups were higher than those before treatment,and those in the observation group were higher than those in the control group(P<0.05).The Portmann score of the two groups after treatment was higher than that before treatment,and that in the observation group was higher than that in the control group(P<0.05).The FDIS and FDIP scores of the two groups after treatment were higher than those before treatment,and those in the observation group were higher than those in the control group(P<0.05).After 7 months of follow-up,the recurrence rate of the observation group(3.33%)was lower than that of the control group(16.67%)(P<0.05).Conclusion Qianzheng powder combined with mecobalamin has a good effect in the treatment of peripheral facial paralysis,which can reduce the symptoms of facial paralysis,promote the recovery of facial nerve function,and reduce the facial disability index and recurrence rate.It is worthy of clinical application.

关 键 词：牵正散 甲钴胺 周围性面神经麻痹 面神经功能 

分 类 号：R277.7[医药卫生—中医学]